当前位置: 首页 > 期刊 > 《中国医学创新》 > 2015年第35期
编号:12760651
miR—195表达调控对大肠癌细胞HT—29增殖和凋亡的影响及其机制探讨(3)
http://www.100md.com 2015年12月15日 中国医学创新 2015年第35期
     [3] Yang O,Huang J,Lin S.Regulatory effects of miRNA on gastric cancer cells[J].Oncol Lett,2014,8(2):651-656.

    [4] Li X,Shi Y,Yin Z,et al.An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma[J].J Transl Med,2014,12(4):159.

    [5] Corté H,Manceau G,Blons H,et al.MicroRNA and colorectal cancer[J].Dig Liver Dis,2012,44(3):195-200.

    [6] Wu W K,Law P T,Lee C W,et al.MicroRNA in colorectal cancer: from benchtop to bedside[J].Carcinogenesis,2011,32(3):247-253.
, http://www.100md.com
    [7] Komatsu S,Ichikawa D,Takeshita H,et al.Circulating miR-18a: a sensitive cancer screening biomarker in human cancer[J].In Vivo,2014,28(3):293-297.

    [8] Chu D,Zheng J,Li J,et al.MicroRNA-630 is a prognostic marker for patients with colorectal cancer[J].Tumour Biol,2014,35(10):9787-9792.

    [9] Schou J V,Rossi S,Jensen B V,et al.miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-kras mutant patients treated with 3rd line cetuximab and irinotecan[J].PLoS One,2014,9(6):e99 886.
, 百拇医药
    [10] Ueda Y,Ando T,Nanjo S,et al.DNA methylation of microrna-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis[J].Dig Dis Sci,2014,59(10):2444-2451.

    [11] Wang L,Qian L,Li X,et al.MicroRNA-195 inhibits colorectal cancer cell proliferation,colony-formation and invasion through targeting CARMA3[J].Mol Med Rep,2014,10(1):473-478.

    [12] Zhang Y,Wang X,Xu B,et al.Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer[J].Oncol Rep,2013,30(4):1976-1984.
, 百拇医药
    [13] Guo H,Li W,Zheng T,et al.miR-195 Targets HDGF to inhibit proliferation and invasion of NSCLC cells[J].Tumour Biol,2014,35(9):8861-8866.

    [14] Mao J H,Zhou R P,Peng A F,et al.microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN[J].Oncol Lett,2012,4(5):1125-1129.

    [15] Yang G,Wu D,Zhu J,et al.Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1[J].Oncol Rep,2013,30(2):877-889.
, 百拇医药
    [16] Chabre O,Libé R,Assie G,et al.Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients[J].Endocr Relat Cancer,2013,20(4):579-594.

    [17] Ishigami S I,Arii S,Furutani M,et al.Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer[J].Br J Cancer,1998,78(10):1379-1384.

    [18] Qiu J F,Zhang Z Q,Wang Y,et al.Lentivirus-mediated RNAi knockdown of VEGFA in RKO colorectal cancer cells decreases tumor formation and growth in vitro and in vivo[J].Int J Clin Exp Pathol,2012,5(4):290-298.
, 百拇医药
    [19] Tai J,Wang G,Liu T,et al.Effects of siRNA targeting c-myc and vegf on human colorectal cancer volo cells[J].J Biochem Mol Toxicol,2012,26(12):499-505.

    [20] Wang S,Liu H,Ren L,et al.Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference[J].Neoplasia,2008,10(4):399-407.

    [21] Yin Y,Cao L Y,Wu W Q,et al.locking effects of siRNA on VEGF expression in human colorectal cancer cells[J].World J Gastroenterol,2010,16(9):1086-1092.

    (收稿日期:2015-08-20) (本文编辑:周亚杰), 百拇医药(吴巍芸)
上一页1 2 3